3 completed. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 1 | Completed 1 |
Follow isoquercitrin: new trials by email Literature Review of isoquercitrin trials Research Report on isoquercitrin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fixed Dose Flavonoid Isoquercetin on Thrombo-Inflammatory Biomarkers in Subjects With Stable Sickle Cell Disease Isoquercetin, Placebo - Sickle Cell Disease | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 46 | 2020-11-02 | 2024-01-02 |
| Nitrite, Isoquercetin and Endothelial Dysfunction (NICE) Trial Immediate release sodium nitrite, Isoquercetin, placebos - Chronic Kidney Disease | Phase 2 | Completed | Tulane University | 70 | 2016-03-01 | 2021-04-20 |
| Cancer Associated Thrombosis and Isoquercetin (CATIQ) Isoquercetin - Thromboembolism of Vein VTE in Colorectal Cancer, Thromboembolism of Vein in Pancreatic Cancer | Phase 2 / Phase 3 | Completed | Jeffrey Zwicker, MD | 64 | 2015-01-01 | 2021-03-03 |
Anemia, Sickle Cell (1) · Inflammation (1) · Renal Insufficiency, Chronic (1) · Venous Thrombosis (1)
Jeffrey Zwicker, MD (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · Tulane University (1)
United States (3)
Arun S Shet, M.D. (1) · Jeffrey Zwicker, MD (1) · Jing Chen, MD (1)
PMID 30652973, PMID 33023894, PMID 37916745, PMID 38157227
U54GM104940 (1)